Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 7424
  • 7425
  • 7426
  • …
  • ›
  • »

2025-11-13

DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025

2025-11-13

Catheter Precision (VTAK) Reports Third Quarter and First Nine Months 2025 Results of Operations

2025-11-13

NANOBIOTIX Announces Curadigm Nanoprimer Platform Advancements With Updated Plans for Internal Pipeline Development and External Collaborations

2025-11-13

Astrotech Reports First Quarter of Fiscal Year 2026 Financial Results

2025-11-13

Cytosorbents Non-GAAP EPS of -$0.04, revenue of $9.5M misses by $0.52M

2025-11-13

Relmada Therapeutics GAAP EPS of -$0.30

2025-11-13

STRATA Skin Sciences GAAP EPS of -$0.36 beats by $0.17, revenue of $6.93M misses by $0.79M

2025-11-13

Omeros Corporation Reports Third Quarter 2025 Financial Results

2025-11-13

Rekor Systems GAAP EPS of -$0.03 beats by $0.02, revenue of $14.2M beats by $1.35M

2025-11-13

Intchains Group Limited Reports Third Quarter and Nine Months 2025 Financial Results

2025-11-13

Autolus Therapeutics to Participate in the Jefferies Global Healthcare Conference in London

2025-11-13

Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update

  • «
  • ‹
  • …
  • 7424
  • 7425
  • 7426
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies